infinit Bio
Berlin
About infinit Bio
infinit Bio manufactures psychedelics through biosynthesis. Building the first, in-vitro (cell-free) biomanufacturing platform allows infinit Bio to unchain psychedelic therapy developers from the old pharma supply- and value-chain.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $170.0K
- Funding stage: Seed
- Last round: Pre-Seed (Apr 2022)
- Website: infinit.bio
Industries & Categories
Biotechnology, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/infinit-bio-2216584 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.